Literature DB >> 6781682

Clinical pharmacology. Adverse reactions to drugs.

M D Rawlins.   

Abstract

Mesh：

Year:  1981        PMID： 6781682      PMCID： PMC1504743          DOI： 10.1136/bmj.282.6268.974

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  3 in total

1.  HEREDITARY TRANSMISSION OF EXCEPTIONAL RESISTANCE TO COUMARIN ANTICOAGULANT DRUGS. THE FIRST REPORTED KINDRED.

Authors:  R A O'REILLY; P M AGGELER; M S HOAG; L S LEONG; M L KROPATKIN
Journal:  N Engl J Med       Date:  1964-10-15       Impact factor: 91.245

2.  Pharmacokinetics and pharmacodynamics of warfarin at steady state.

Authors:  P A Routledge; P H Chapman; D M Davies; M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1979-09       Impact factor: 4.335

Review 3.  Current status of estrogen and progesterone receptors in breast cancer.

Authors:  W L McGuire; K B Horwitz; O H Pearson; A Segaloff
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860
  3 in total
  38 in total

1.  Academic detailing improves identification and reporting of adverse drug events.

Authors:  R G Schlienger; T F Lüscher; R A Schoenenberger; W E Haefeli
Journal:  Pharm World Sci       Date:  1999-06

Review 2.  Methods and systems to detect adverse drug reactions in hospitals.

Authors:  P A Thürmann
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

3.  Economic costs of adverse drug reactions.

Authors:  M N Dukes
Journal:  Pharmacoeconomics       Date:  1992-03       Impact factor: 4.981

Review 4.  Joining the DoTS: new approach to classifying adverse drug reactions.

Authors:  J K Aronson; R E Ferner
Journal:  BMJ       Date:  2003-11-22

5.  Preventability of drug-related harms - part II: proposed criteria, based on frameworks that classify adverse drug reactions.

Authors:  Jeffrey K Aronson; Robin E Ferner
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

Review 6.  Preventability of drug-related harms - part I: a systematic review.

Authors:  Robin E Ferner; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

Review 7.  Clarification of terminology in drug safety.

Authors:  Jeffrey K Aronson; Robin E Ferner
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

8.  Computerized surveillance of adverse drug events in hospital patients. 1991.

Authors:  D C Classen; S L Pestotnik; R S Evans; J P Burke
Journal:  Qual Saf Health Care       Date:  2005-06

Review 9.  Statins and pancreatitis: a systematic review of observational studies and spontaneous case reports.

Authors:  Sonal Singh; Yoon K Loke
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

10.  Detection of adverse drug reactions in a neurological department: comparison between intensified surveillance and a computer-assisted approach.

Authors:  Petra A Thuermann; Roland Windecker; Joachim Steffen; Markus Schaefer; Ute Tenter; Erich Reese; Hermann Menger; Klaus Schmitt
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.